William Tyler Turchan

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr et al. · Scientific Reports · 2021 · 98 citations · Full text

Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade

Liam F. Spurr, Carlos Alberto Martínez, Wenjun Kang et al. · Nature Cancer · 2022 · 89 citations

Radiation Oncology, Cancer Immunosurveillance, Medicine +9

DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo

Marc S. Mendonca, William Tyler Turchan, Melanie E. Alpuche et al. · Free Radical Biology and Medicine · 2017 · 32 citations · Full text

Tumor Xenografts, Nf-κb Activity, Medicine +8

PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy

William Tyler Turchan, G. Kauffmann, Pritesh Patel et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 20 citations

Urology, Radiation Medicine, Radiation Therapy +7

Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer?

Aritrick Chatterjee, William Tyler Turchan, Xiaobing Fan et al. · Academic Radiology · 2021 · 19 citations

Adaptive Radiotherapy, Medical Imaging, Medicine +8